Medizinische Universität Graz - Research portal

• Go directly to the nagivation.
• Go directly to the content.

• Print view.
• German.
• Contact.
• Data entry.
• Start.
• Open Access.

European Medicines Research Training Network

Local Subprojectlead:

Zatloukal Kurt

Duration:

01.10.2009-30.09.2014

Programme:

EU (FP-7)

Subprogramme

IMI Innovative Medicine Initiative Call 14

Type of Research

other

Staff

Zatloukal, Kurt, Project Leader

MUG Research Units

Diagnostic and Research Institute of Pathology

Project partners

Astrazeneca AB, Sweden

Bayer Schering Pharma AG, Germany

Boehringer Ingelheim International GmbH, Germany

Centre de Recherche en Biologie et Medecine, France

European Molecular Biology Laboratory, Germany

F. Hoffmann-La Roche AG, Switzerland

Genzyme Europe B.V., Netherlands

Glaxosmithkline Research and Development LTD., United Kingdom

H. Lundbeck A/S, Denmark

Helmholtz Zentrum München-German Reasearch Center for Environmental Health , Germany

Helmoltz-Centre for Infektion Research, Germany

Institut de la Sante de la Recherche Medicale (INSERM), France

Janssen Pharmaceutica N.V., Belgium

Karolinska Institut, Sweden

Karolinska University Hospital, Sweden

Laboratorios Almirall S.A., Spain

Laboratorios del Dr Esteve, S.A., Spain

Medizinische Universität Wien (MUW), Austria

Ministry of Health, Social and Family Affairs, Medical Research Council, Hungary

Novartis Pharma AG, Switzerland

NovoNordisk, Denmark

ORION Corporation, Finland

Pfizer LTD, United Kingdom

Sanofi Aventis Deutschland GmbH, Germany

The Chancellor, Masters and Scholars of the University of Oxford, United Kingdom

UCB Pharma SA, Belgium

University of Manchester, United Kingdom

Funded by

Europäische Kommission, Rue de la Loi, Brussels, Belgium